Pharma's Almanac

Mobile Navigation

Subscribe for the Newsletter

Articles
Expert Interviews
Roundtable
Press Releases
Videos

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Centers for Disease Control and Prevention

Sort By

1 / 1

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Our Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2025 PHARMA’S ALMANAC. All rights reserved.

1 / 1

Gilead Makes $100 Million Commitment to Fighting HIV/AIDs

Research

Gilead Makes $100 Million Commitment to Fighting HIV/AIDs

Emilie Branch

Pharma's Almanac

PAO-M12-17-NI-038Dec 28, 2017

US Now Has an Approved Treatment for Chagas Disease

FDA Approval

US Now Has an Approved Treatment for Chagas Disease

Emilie Branch

Pharma's Almanac

PAO-M09-17-NI-012Sep 08, 2017